We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit
FLACU

Delisted

FLACU was delisted on the 22nd of November, 2022.

Back to rankings

26 hedge funds and large institutions have $46.4M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less capital invested

Capital invested by funds: $51.3M → $46.4M (-$4.92M)

19% less funds holding

Funds holding: 32 → 26 (-6)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.95K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.26M
2
GCL
Glazer Capital LLC
New York
-$1.55M
3
BCM
BlueCrest Capital Management
Jersey
-$1M
4
BCM
Bluefin Capital Management
New York
-$682K
5
BFM
Boothbay Fund Management
New York
-$210K
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$15.1M – – –
RCM
2
RA Capital Management
Massachusetts
$9.82M – – –
BI
3
BVF Inc
California
$4.93M – – –
Ensign Peak Advisors
4
Ensign Peak Advisors
Utah
$4.44M – – –
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$3.01M – – –
MF
6
Magnetar Financial
Illinois
$2M – – –
GCL
7
Glazer Capital LLC
New York
$1.3M -$1.55M -155,002 -54%
CCM
8
Context Capital Management
California
$1.22M – – –
WCMNY
9
Westchester Capital Management (New York)
New York
$936K – – –
TAL
10
TIG Advisors LLC
New York
$883K -$56.6K -5,651 -6%
HF
11
HRT Financial
New York
$856K – – –
IC
12
Ikarian Capital
Texas
$725K -$18.9K -1,882 -3%
LIM
13
Longfellow Investment Management
Massachusetts
$343K – – –
MTCM
14
Mint Tower Capital Management
Netherlands
$197K – – –
WC
15
Wealthspring Capital
New York
$163K – – –
WMSA
16
Weiss Multi-Strategy Advisers
New York
$162K – – –
BFM
17
Boothbay Fund Management
New York
$107K -$210K -20,941 -66%
DIG
18
DeepCurrents Investment Group
New York
$107K – – –
GCIA
19
Gabelli & Co Investment Advisers
New York
$102K – – –
AM
20
Anqa Management
New York
$58K – – –
UBS Group
21
UBS Group
Switzerland
$6K +$2.95K +294 +103%
TRCT
22
Tower Research Capital (TRC)
New York
$5K – – –
Morgan Stanley
23
Morgan Stanley
New York
$1K -$3.71K -370 -79%
CIM
24
Cowen Investment Management
New York
$401 – – –
Walleye Capital
25
Walleye Capital
New York
$135 -$45.1K -4,500 -25%
1
2

FLACU Hedge Fund Activity: Q3 2021 in Review

26 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q3 2021, worth a combined $46.4M — down 9.6% from $51.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FLACU and 0 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $2.95K. The largest seller was Millennium Management, exiting entirely with an estimated $2.26M sold.

  • 26 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q3 2021, down from 32 in Q2 2021.
  • Funds reported $46.4M of Frazier Lifesciences Acquisition Corporation Unit stock for Q3 2021, down 9.6% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q3 2021 and 6 closed out, a net change of -6 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q3 2021 was UBS Group, an estimated $2.95K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q3 2021 was Millennium Management, an estimated $2.26M sold.

Based on aggregated 13F filings for Q3 2021.